Calliditas Therapeutics (CALT)
(Delayed Data from NSDQ)
$22.00 USD
-0.19 (-0.86%)
Updated May 20, 2024 03:51 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (83 out of 249)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.52 | 9.99 |
Current Quarter Estimate | -0.14 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -0.67 | -0.59 | 52.54 |
Next Quarter Estimate | -0.05 | -2.00 | 61.00 |
Next Year Estimate | 3.45 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 118.29 | 12.40 | 15.67 |
Next Year | 1,050.00 | 14.90 | 9.31 |
Last 5 Years | NA | 4.90 | 8.10 |
Next 5 Years | NA | 22.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 20.94 | 1.86 |
Price/Cash Flow (MRFY) | NA | 8.87 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -38.72% | -61.28% |
Return on Equity (TTM) | -104.48% | -52.46% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.